Ajani JA - Search Results

1

Evolution of gastric surgery techniques and outcomes.

Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Shiozaki H, et al. Among authors: ajani ja. Chin J Cancer. 2016 Jul 26;35(1):69. doi: 10.1186/s40880-016-0134-y. Chin J Cancer. 2016. PMID: 27460019 Free PMC article. Review.

2

Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma.

Partyka S, Dumas P, Ajani J. Partyka S, et al. Cancer. 1999 Jun 1;85(11):2336-9. doi: 10.1002/(sici)1097-0142(19990601)85:11<2336::aid-cncr6>3.0.co;2-i. Cancer. 1999. PMID: 10357402 Clinical Trial.

3

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study.

Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C. Ajani JA, et al. Cancer. 2002 Feb 1;94(3):641-6. doi: 10.1002/cncr.10279. Cancer. 2002. PMID: 11857295 Free article. Clinical Trial.

4

Outcomes after emergency surgery for gastric perforation or severe bleeding in patients with gastric cancer.

Kasakura Y, Ajani JA, Mochizuki F, Morishita Y, Fujii M, Takayama T. Kasakura Y, et al. Among authors: ajani ja. J Surg Oncol. 2002 Aug;80(4):181-5. doi: 10.1002/jso.10127. J Surg Oncol. 2002. PMID: 12210031

5

Chemoradiation for resectable gastric cancer.

Xiong HQ, Gunderson LL, Yao J, Ajani JA. Xiong HQ, et al. Among authors: ajani ja. Lancet Oncol. 2003 Aug;4(8):498-505. doi: 10.1016/s1470-2045(03)01170-7. Lancet Oncol. 2003. PMID: 12901965 Review.

6

Gastric cancer: advances in adjuvant and adjunct therapy.

Higuchi K, Phan A, Ajani JA. Higuchi K, et al. Among authors: ajani ja. Curr Treat Options Oncol. 2003 Oct;4(5):413-9. doi: 10.1007/s11864-003-0042-7. Curr Treat Options Oncol. 2003. PMID: 12941201 Review.

7

Combined-modality therapy for gastric cancer.

Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, Ajani JA. Yao JC, et al. Among authors: ajani ja. Semin Surg Oncol. 2003;21(4):223-7. doi: 10.1002/ssu.10040. Semin Surg Oncol. 2003. PMID: 14648779 Review.

8

Gastric carcinoma.

Phan AT, Ajani JA. Phan AT, et al. Among authors: ajani ja. Curr Oncol Rep. 2004 May;6(3):192-8. doi: 10.1007/s11912-004-0049-7. Curr Oncol Rep. 2004. PMID: 15066230 Review.

9

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Ajani JA, et al. Cancer. 2004 Jun 1;100(11):2347-54. doi: 10.1002/cncr.20284. Cancer. 2004. PMID: 15160337 Free article.

10

Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus.

Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Rohatgi PR, et al. Among authors: ajani ja. Cancer. 2005 Oct 1;104(7):1349-55. doi: 10.1002/cncr.21346. Cancer. 2005. PMID: 16130133 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

797 results

Search Page

Filters